B19 infection can be acquired by transmission with blood factors in pa
tients with congenital bleeding disorders, requiring clotting factor c
oncentrates. In immunodeficient patients, the failure of immunity to c
lear B19 virus may produce persistent infections. The presence of B19
DNA in blood samples from seven haemophilic patients with concomitant
HIV-1 infection was studied over a period of three-to-four years. Dot
blot hybridization assays with DNA and RNA probes were used to detect
medium high viremias, and polymerase chain reaction (PCR) to detect ve
ry low viremic titres. Three patients were negative for B19 DNA in all
the blood samples, while four patients were persistently positive for
B19 DNA. Viral persistence, which in one patient was detected through
out the study period (40 months), occurred at low titre in all four po
sitive patients with some recurrent increases in viral titre. In the f
our patients persistently positive for B19 DNA, acute or chronic clini
cal symptoms and signs that could be associated with B19 were not note
d when virus was present at low titre (B19 DNA detectable only by PCR)
. When patients had a higher viral titre (B19 DNA detectable by dot bl
ot hybridization) acute manifestations (aplastic crisis, Fifth disease
, fevers, pneumonitis) were found. (C) 1995 Wiley-Liss, Inc.